Senior insider sale
Chief Operating Officer at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$128.2K
11.11K shares
What this filing means
BUNKER KEVIN D. plans to sell 11.11K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $128.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2024ACC: 0001725160-24-000021
Officer· Chief Operating Officer
Since Apr 2020
11.11K
Shares to sell
$128.2K
Approx. market value
11.11K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/1/2024
11.11KTotal acquired11.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2024 | Restricted Stock Unit Release NA | 11.11K | — |
| Total | 11.11K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.11K
Market value
$128.2K
2/2/2024
Total
Units
11.11K
Value
$128.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2024 | 11.11K | $128.2K | NASDAQ | Planned |
| Total | 11.11K | $128.2K | ||